Annual Operating Profit
-$134.43 M
-$71.93 M-115.08%
December 31, 2023
Summary
- As of February 7, 2025, IDYA annual operating income is -$134.43 million, with the most recent change of -$71.93 million (-115.08%) on December 31, 2023.
- During the last 3 years, IDYA annual operating profit has fallen by -$99.08 million (-280.34%).
- IDYA annual operating profit is now -831.08% below its all-time high of -$14.44 million, reached on December 31, 2017.
Performance
IDYA Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$66.89 M
-$1.97 M-3.03%
September 30, 2024
Summary
- As of February 7, 2025, IDYA quarterly operating income is -$66.89 million, with the most recent change of -$1.97 million (-3.03%) on September 30, 2024.
- Over the past year, IDYA quarterly operating profit has dropped by -$24.98 million (-59.58%).
- IDYA quarterly operating profit is now -10235.30% below its all-time high of $660.00 thousand, reached on September 30, 2022.
Performance
IDYA Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$224.75 M
-$33.37 M-17.43%
September 30, 2024
Summary
- As of February 7, 2025, IDYA TTM operating income is -$224.75 million, with the most recent change of -$33.37 million (-17.43%) on September 30, 2024.
- Over the past year, IDYA TTM operating profit has dropped by -$90.32 million (-67.19%).
- IDYA TTM operating profit is now -3592.36% below its all-time high of -$6.09 million, reached on March 31, 2018.
Performance
IDYA TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
IDYA Operating Profit Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -115.1% | -59.6% | -67.2% |
3 y3 years | -280.3% | -59.6% | -67.2% |
5 y5 years | -269.1% | -436.1% | -381.7% |
IDYA Operating Profit Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -167.4% | at low | <-9999.0% | at low | -347.1% | at low |
5 y | 5-year | -280.3% | at low | <-9999.0% | at low | -637.8% | at low |
alltime | all time | -831.1% | at low | <-9999.0% | at low | -3592.4% | at low |
IDEAYA Biosciences Operating Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$66.89 M(+3.0%) | -$224.75 M(+17.4%) |
Jun 2024 | - | -$64.93 M(+27.3%) | -$191.39 M(+20.2%) |
Mar 2024 | - | -$51.02 M(+21.7%) | -$159.17 M(+18.4%) |
Dec 2023 | -$134.43 M(+115.1%) | -$41.92 M(+25.0%) | -$134.43 M(+13.0%) |
Sep 2023 | - | -$33.53 M(+2.5%) | -$118.96 M(+40.3%) |
Jun 2023 | - | -$32.71 M(+24.5%) | -$84.77 M(+13.7%) |
Mar 2023 | - | -$26.28 M(-0.6%) | -$74.56 M(+19.3%) |
Dec 2022 | -$62.50 M(+24.3%) | -$26.44 M(-4106.5%) | -$62.50 M(+14.8%) |
Sep 2022 | - | $660.00 K(-102.9%) | -$54.43 M(-18.5%) |
Jun 2022 | - | -$22.50 M(+58.2%) | -$66.80 M(+20.7%) |
Mar 2022 | - | -$14.22 M(-22.6%) | -$55.35 M(+10.1%) |
Dec 2021 | -$50.27 M | -$18.37 M(+56.8%) | -$50.27 M(+35.2%) |
Sep 2021 | - | -$11.71 M(+6.0%) | -$37.18 M(+22.1%) |
Jun 2021 | - | -$11.05 M(+21.0%) | -$30.46 M(-4.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2021 | - | -$9.13 M(+73.0%) | -$32.00 M(-9.5%) |
Dec 2020 | -$35.34 M(-20.2%) | -$5.28 M(+5.7%) | -$35.34 M(-14.6%) |
Sep 2020 | - | -$5.00 M(-60.3%) | -$41.38 M(-13.8%) |
Jun 2020 | - | -$12.59 M(+0.9%) | -$48.01 M(+2.9%) |
Mar 2020 | - | -$12.48 M(+10.2%) | -$46.66 M(+5.4%) |
Dec 2019 | -$44.27 M(+21.6%) | -$11.32 M(-2.6%) | -$44.27 M(+5.2%) |
Sep 2019 | - | -$11.62 M(+3.5%) | -$42.09 M(-4.5%) |
Jun 2019 | - | -$11.23 M(+11.3%) | -$44.09 M(+9.1%) |
Mar 2019 | - | -$10.09 M(+10.5%) | -$40.42 M(+11.0%) |
Dec 2018 | -$36.42 M(+152.2%) | -$9.13 M(-33.0%) | -$36.42 M(+33.5%) |
Sep 2018 | - | -$13.63 M(+80.0%) | -$27.28 M(+99.8%) |
Jun 2018 | - | -$7.57 M(+24.4%) | -$13.66 M(+124.4%) |
Mar 2018 | - | -$6.09 M | -$6.09 M |
Dec 2017 | -$14.44 M | - | - |
FAQ
- What is IDEAYA Biosciences annual operating income?
- What is the all time high annual operating profit for IDEAYA Biosciences?
- What is IDEAYA Biosciences annual operating profit year-on-year change?
- What is IDEAYA Biosciences quarterly operating income?
- What is the all time high quarterly operating profit for IDEAYA Biosciences?
- What is IDEAYA Biosciences quarterly operating profit year-on-year change?
- What is IDEAYA Biosciences TTM operating income?
- What is the all time high TTM operating profit for IDEAYA Biosciences?
- What is IDEAYA Biosciences TTM operating profit year-on-year change?
What is IDEAYA Biosciences annual operating income?
The current annual operating profit of IDYA is -$134.43 M
What is the all time high annual operating profit for IDEAYA Biosciences?
IDEAYA Biosciences all-time high annual operating income is -$14.44 M
What is IDEAYA Biosciences annual operating profit year-on-year change?
Over the past year, IDYA annual operating income has changed by -$71.93 M (-115.08%)
What is IDEAYA Biosciences quarterly operating income?
The current quarterly operating profit of IDYA is -$66.89 M
What is the all time high quarterly operating profit for IDEAYA Biosciences?
IDEAYA Biosciences all-time high quarterly operating income is $660.00 K
What is IDEAYA Biosciences quarterly operating profit year-on-year change?
Over the past year, IDYA quarterly operating income has changed by -$24.98 M (-59.58%)
What is IDEAYA Biosciences TTM operating income?
The current TTM operating profit of IDYA is -$224.75 M
What is the all time high TTM operating profit for IDEAYA Biosciences?
IDEAYA Biosciences all-time high TTM operating income is -$6.09 M
What is IDEAYA Biosciences TTM operating profit year-on-year change?
Over the past year, IDYA TTM operating income has changed by -$90.32 M (-67.19%)